Avandia, Rosiglitazone News

As biotech companies and large pharma embark on paths to usher in more effective diabetes drugs to market, one of the more significant concerns regarding diabetes related drug development is safety.

E-mail: Jcha@yuhs.ac 5 Received 2 June 2009; Revised 31 August 2009; Accepted 7 September 2009; Published online 27 October 2009.

From the Center for Translational Research in Biomedical Sciences , Chang Gung Memorial Hospital-Kaohsiung Medical Center; Departments of Medical Education and Research and Neurology , Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan, Republic of China.

Incyte a ' Life After Debt For part I click here On top its JAK programs, Incyte has been developing two additional programs it intends to out-license. The first program is INCB13739 for diabetes, which already reached clinical proof of concept and could be licensed imminently.

Bone fractures are often a symptom of conditions or diseases such as osteoporosis, but could also be side effects associated with certain medications .

Q: I heard that a new oral drug for diabetes was approved. What can you tell me about it? A: The FDA recently approved Onglyza for the treatment of people with type 2 diabetes.

The prescription drug Avandia causes an increase in liver problems, heart problems and bone density problems resulting in fractures.

Insulin resistance, the hallmark of type 2 diabetes and a condition often associated with obesity, is paradoxically also an apparent contributor to muscle wasting and severe fat loss that accompanies some cancers, according to new research.

Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Rapid breathing, confusion, and lethargy are often symptoms of conditions or diseases such as anxiety or metabolic acidosis, but could also be side effects associated with certain medications .

A group of Ontario researchers is calling into question the continued use of the controversial diabetes drug Avandia, saying a competing drug in the same class is as effective and less dangerous.

A study just published on bmj.com reports that rosiglitazone, a drug used to treat type 2 diabetes , is linked with an increased risk of heart failure and death among elder patients compared to pioglitazone, which is a similar drug.

Rosiglitazone, brand name Avandia, has higher rates of heart failure and death than similar alternative Scientists say doctors should stop prescribing a commonly used diabetes drug, after studies show that it is linked to higher rates of heart failure and death than a similar alternative.

Main Category: Diabetes Also Included In: Heart Disease ; Cardiovascular / Cardiology Article Date: 19 Aug 2009 - 13:00 PDT Rosiglitazone, a drug used to treat type 2 diabetes , is associated with an increased risk of heart failure and death among older patients compared to a similar drug , concludes a study published on bmj.com today.

Rosiglitazone, a drug used to treat type 2 diabetes, is associated with an increased risk of heart failure and death among older patients compared to a similar drug , concludes a study published on bmj.com today.

A DRUG to treat patients with Type 2 diabetes is linked to an increased risk of heart failure and its continued use may not be justified, a study said yesterday.

The type 2 diabetes drug Avandia increases the risk of heart failure and death more than another drug in the same class, Actos , new Canadian research contends.

A new study has raised more red flags about Avandia, a widely-used drug for patients with Type 2 diabetes, finding it carries a higher risk of heart failure and death than a similar drug.

The American Diabetes Association held its 2009 annual meeting from June 5 to 9 in New Orleans.

A large study from British Columbia, Canada is pointing to an increased fracture risk with thiazolidinediones , used in the treatment of type 2 diabetes [1]. The study, which reviewed fracture risk in more than 84 000 patients receiving either rosiglitazone or pioglitazone vs a sulfonylurea, found that both men and women are at increased risk of ...